Patents by Inventor Josée Morissette
Josée Morissette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20120290976Abstract: Techniques for presenting a three-dimensional (3D) anatomical representation of an anatomical structure are described. 3D models of various anatomical structures may be stored as prepackaged anatomical data. A user device, e.g., a networked workstation, may receive the prepackaged anatomical data from a networked computing device, e.g., a server, and present at least a portion of a 3D model as a 3D anatomical representation. The user device may also present a menu with the 3D anatomical representation that allows the user to manipulate the 3D anatomical representation and measure various aspects of the 3D anatomical representation. In some examples, the user device may also present a representation of a medical device in conjunction with the 3D anatomical representation.Type: ApplicationFiled: May 13, 2011Publication date: November 15, 2012Applicant: MEDTRONIC, INC.Inventors: Ryan Phillip Lahm, Josee Morissette, Michael J. Schendel, Christopher H. Johnson Bidler, Walton W. Baxter, III, Karel F.A.A. Smits
-
Patent number: 7797030Abstract: A method for localizing an internal body structure during an image-guided procedure that includes obtaining a three dimensional image of a body portion containing a targeted structure and selected reference structures; determining a set of landmark point coordinates for defining the location of each of the targeted and reference structures; computing triangulation parameters relating the location of the landmark points for the targeted structure and the reference structures; and, during an image-guided procedure, using the computed triangulation parameters to plot an estimated location of the targeted structure on an intra-operative image in which the reference structures have been identified.Type: GrantFiled: November 12, 2004Date of Patent: September 14, 2010Assignee: Medtronic, Inc.Inventors: Ryan P. Lahm, Walton W. Baxter, III, Josee Morissette, Timothy G. Laske
-
Patent number: 7731653Abstract: The present invention provides delivery systems for and methods of delivering conduction protein genetic material to cardiac cells in localized areas of the heart to improve the conductance therein. More specifically, there is provided a system and method for delivering connexin proteins or nucleic acid molecules encoding connexin proteins to a site in the heart which has been determined by mapping procedures to have a conduction disturbance. For cases where conduction is impaired, selected genetic material is delivered to cells around the disturbance area, in order to enhance overall conductivity patterns; in other cases, genetic material is selected to slow conduction in affected areas, so as to prevent, e.g., brady-tachy syndrome.Type: GrantFiled: May 31, 2006Date of Patent: June 8, 2010Assignee: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josée Morissette
-
Patent number: 7337011Abstract: The present invention provides delivery systems for and methods of delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave. More specifically, there is provided a system and method for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.Type: GrantFiled: May 26, 2004Date of Patent: February 26, 2008Assignee: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josée Morissette
-
Publication number: 20080008688Abstract: The present invention provides delivery systems for and methods of delivering conduction protein genetic material to cardiac cells in localized areas of the heart to improve the conductance therein. More specifically, there is provided a system and method for delivering connexin proteins or nucleic acid molecules encoding connexin proteins to a site in the heart which has been determined by mapping procedures to have a conduction disturbance. For cases where conduction is impaired, selected genetic material is delivered to cells around the disturbance area, in order to enhance overall conductivity patterns; in other cases, genetic material is selected to slow conduction in affected areas, so as to prevent, e.g., brady-tachy syndrome.Type: ApplicationFiled: May 31, 2006Publication date: January 10, 2008Applicant: Medtronic, Inc.Inventors: Kenneth Stokes, Josee Morissette
-
Patent number: 7094201Abstract: The present invention provides delivery systems for and methods of delivering conduction protein genetic material to cardiac cells in localized areas of the heart to improve the conductance therein. More specifically, there is provided a system and method for delivering connexin proteins or nucleic acid molecules encoding connexin proteins to a site in the heart which has been determined by mapping procedures to have a conduction disturbance. For cases where conduction is impaired, selected genetic material is delivered to cells around the disturbance area, in order to enhance overall conductivity patterns; in other cases, genetic material is selected to slow conduction in affected areas, so as to prevent, e.g., brady-tachy syndrome.Type: GrantFiled: August 18, 1999Date of Patent: August 22, 2006Assignee: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josée Morissette
-
Patent number: 7045279Abstract: An isolated heart preparation in which essentially normal pumping activity of all four chambers of the heart is preserved, allowing for the use of the preparation in conjunction with investigations of electrode leads, catheters, cardiac implants and other medical devices intended to be used in or on a beating heart. The preparation may also be employed to investigate heart functions, in the presence or absence of such medical devices. In order to allow for visualization of heart structures and devices located within the chambers of the heart, a clear perfusate such as a modified Krebs buffer solution with oxygenation is circulated through all four chambers of the heart and the coronary vasculature. The preparation and recordings of the preparation may be used in conjunction with the design, development and evaluation of devices for use in or on the heart, as well as for use as an investigational and teaching aid to assist physicians and students in understanding the operation of the heart.Type: GrantFiled: October 15, 1999Date of Patent: May 16, 2006Assignee: Medtronic, Inc.Inventors: Timothy G. Laske, Paul A. Iaizzo, Mark A. Hjelle, Josée Morissette, Dale A. Wahlstrom
-
Publication number: 20050148850Abstract: A method for localizing an internal body structure during an image-guided procedure that includes obtaining a three dimensional image of a body portion containing a targeted structure and selected reference structures; determining a set of landmark point coordinates for defining the location of each of the targeted and reference structures; computing triangulation parameters relating the location of the landmark points for the targeted structure and the reference structures; and, during an image-guided procedure, using the computed triangulation parameters to plot an estimated location of the targeted structure on an intra-operative image in which the reference structures have been identified.Type: ApplicationFiled: November 12, 2004Publication date: July 7, 2005Inventors: Ryan Lahm, Walton Baxter, Josee Morissette, Timothy Laske
-
Publication number: 20040242527Abstract: The present invention provides delivery systems for and methods of delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave. More specifically, there is provided a system and method for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.Type: ApplicationFiled: May 26, 2004Publication date: December 2, 2004Applicant: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josee Morissette
-
Publication number: 20040236377Abstract: Delivery systems for and methods of delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave, is described herein. More specifically, there is provided a system and method for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.Type: ApplicationFiled: October 14, 2003Publication date: November 25, 2004Applicant: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josee Morissette
-
Patent number: 6801805Abstract: The present invention provides delivery systems for and methods of delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave. More specifically, there is provided a system and method for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.Type: GrantFiled: July 2, 2001Date of Patent: October 5, 2004Assignee: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josée Morissette
-
Patent number: 6665563Abstract: The present invention provides delivery systems for and methods of delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave. More specifically, there is provided a system and method for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.Type: GrantFiled: July 2, 2001Date of Patent: December 16, 2003Assignee: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josée Morissette
-
Publication number: 20030191500Abstract: The present invention provides delivery systems for and methods of delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave. More specifically, there is provided a system and method for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.Type: ApplicationFiled: July 2, 2001Publication date: October 9, 2003Applicant: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josee Morissette
-
Patent number: 6567705Abstract: Delivery systems for and methods of delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave, is described herein. More specifically, there is provided a system and method for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.Type: GrantFiled: February 28, 2000Date of Patent: May 20, 2003Assignee: Medtronic, IncInventors: Kenneth B. Stokes, Josée Morissette
-
Publication number: 20030074024Abstract: The present invention provides delivery systems for and methods of delivering ion channel protein genetic material to cardiac cells in areas adjacent to where an electrode is to be positioned in a patient's heart to improve or correct the signal to noise ratio of cardiac signals, such as the P-wave. More specifically, there is provided a system and method for delivering sodium ion channel proteins or nucleic acid molecules encoding sodium ion channel proteins to a site in the heart adjacent to an electrode to increase the expression of the same, thereby enhancing the cardiac signal amplitude and enabling improved sensing of cardiac signals by an implanted pacemaker.Type: ApplicationFiled: July 2, 2001Publication date: April 17, 2003Applicant: Medtronic, Inc.Inventors: Kenneth B. Stokes, Josee Morissette